D. Oliver

发表

Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat

B. Harvey, Mmalebuso L. Mokoena, D. Oliver, 2010, Metabolic Brain Disease.

Polycyclic Cage Structures as Lipophilic Scaffolds for Neuroactive Drugs

W. Geldenhuys, T. Govender, Hendrik G. Kruger, 2012, ChemMedChem.

Investigations on the Pharmacology of the Cardioprotective Guanidine ME10092

R. Petrovska, J. Wikberg, E. Liepinsh, 2004, Journal of cardiovascular pharmacology.

Appraisal of ozone as biologically active molecule and experimental tool in biomedical sciences

B. Harvey, Mmalebuso L. Mokoena, D. Oliver, 2011, Medicinal Chemistry Research.

Studies on cellular resilience and adaptation following acute and repetitive exposure to ozone in cultured human epithelial (HeLa) cells

D. Oliver, C. B. Brink, Anita Pretorius, 2008, Redox report : communications in free radical research.

Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.

C. J. Van der Schyf, S. Pond, N. Castagnoli, 1996, Life sciences.

The pharmacological effects of ozone on isolated guinea pig tracheal preparations

D. Oliver, C. J. Lotriet, D. P. Venter, 2007, Archives of Toxicology.

A model for agonists acting directly as well as indirectly.

D. Oliver, D. P. Venter, 1987, European journal of pharmacology.

Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.

K. Langen, D. Oliver, I. Dormehl, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cerebral Blood Perfusion after Treatment with Zolpidem and Flumazenil in the Baboon

R. Clauss, D. Oliver, W. Louw, 2002, Arzneimittelforschung.

Cerebral blood flow effects of sodium valproate in drug combinations in the baboon model.

D. Oliver, I. Dormehl, 1998, Arzneimittel-Forschung.

Cyclodipeptides: Structure and conformation of cyclo(tyrosyl-prolyl)

P. Milne, D. Oliver, H. Roos, 1992 .

South African traditional herbal medicines used during pregnancy and childbirth.

D. Oliver, K. Furman, D. Veale, 1992, Journal of ethnopharmacology.

Preliminary isolated organ studies using an aqueous extract of Clivia miniata leaves.

D. Oliver, K. Furman, D. Veale, 1989, Journal of ethnopharmacology.

Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.

B. P. Repsold, J. Joubert, S. Malan, 2017, European journal of medicinal chemistry.

Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates

B. P. Repsold, J. Joubert, S. Malan, 2018, SAR and QSAR in environmental research.

Synthesis and biological activity of D3-trishomocubyl-4-amines.

D. Oliver, T. G. Dekker, T. G. Fourie, 1991, Journal of medicinal chemistry.

Medicinal chemistry of polycyclic cage compounds in drug discovery research

S. Malan, D. Oliver, 2008, Medicinal Chemistry Research.

Pharmacological effects of Agapanthus africanus on the isolated rat uterus.

I. Havlik, D. Oliver, D. Veale, 1999, Journal of ethnopharmacology.

The effects of herbal oxytocics on the isolated "stripped" myometrium model.

I. Havlik, D. Oliver, D. Veale, 2000, Life sciences.

The Elastic Moduli of MnO

D. Oliver, D. W. Oliver, 1969 .

1-methyl-(D3)-trishomocubane

D. Oliver, T. G. Dekker, Miss A Venter, 1980 .

Stereochemistry of 4‐amino‐(D3)‐trishomocubanes. NMR study of 3‐phenyl‐4‐amino‐(D3)‐trishomocubane

P. Wessels, D. Oliver, T. G. Dekker, 1994 .

Pentacyclo[5.4.0.02,6.03,10.05,9]undecylamines. Synthesis and pharmacology

D. Oliver, T. G. Dekker, F. Snyckers, 1991 .

1H and 13C nuclear magnetic resonance study of (D3)‐trishomocuban‐4‐ol and (D3)‐trishomocubanone

K. Pachler, P. Wessels, D. Oliver, 1981 .

In vivo measurements of the cerebral perfusion and cardiovascular effects of the novel guanidine ME10092 in the non-human primate, Papio ursinus.

E. J. van Rensburg, M. Dambrova, D. Oliver, 2004, Life sciences.

Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranes.

J. Wikberg, G. Tiger, M. Dambrova, 1998, Biochemical pharmacology.

SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs.

D. Oliver, I C Dormehl, B Jordaan, 1999, Clinical nuclear medicine.

Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

B. Harvey, D. Oliver, C. B. Brink, 2004, British journal of clinical pharmacology.

Crystal Structure of a Rearranged Cage Compound, 3-Hydroxy-4-aza-8-oxoheptacyclo [9.4.1.02,10.03,14.04,9.09,13.012,15]tetradecane

M. Caira, L. H. Prins, S. Malan, 2008 .

Effect of sumatriptan on cerebral blood flow in the baboon model.

D. Oliver, I. Dormehl, N. Hugo, 1994, Arzneimittel-Forschung.

Nitric Oxide Synthase Inhibition by Pentacycloundecane Conjugates of Aminoguanidine and Tryptamine

S. Malan, D. Oliver, A. D. de Vries, 2009, Archiv der Pharmazie.

Antiviral properties of 4-amino-(D3)-trishomocubanes.

D. Oliver, T. G. Dekker, F. Snyckers, 1991, Arzneimittel-Forschung.

High-resolution solid-state carbon-13 nuclear magnetic resonance spectra of mofebutazone, phenylbutazone, and oxyphenbutazone in relation to X-ray crystallographic data.

P. L. Wessels, D. Oliver, M. Stoltz, 1991, Journal of pharmaceutical sciences.

Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide.

D. Oliver, I. Dormehl, N. Hugo, 1996, Arzneimittel-Forschung.

Structure and conformation of the sodium chloride salt of N-t-Boc-Phenylalanyl-Proline (Boc-Phe-Pro·NaCl) and the dihydrate of N-t-Boc-Tyrosyl-Proline (Boc-Tyr-Pro·2H2O)

P. Milne, P. H. V. Rooyen, D. Oliver, 1997 .

Non-human primate SPECT model for determining cerebral perfusion effects of cerebrovasoactive drugs acting via multiple modes of pharmacological action

D. Oliver, W. Louw, I. Dormehl, 2005, Journal of the Neurological Sciences.

Cerebral Blood Flow Effects of the Nitric Oxide Donor, Nitroglycerin and its Drug Combinations in the Non-Human Primate Model

D. Oliver, I. Dormehl, 1999, Arzneimittelforschung.

Design of agents interacting with immunoregulating proteins: Potential inhibitors of the phenylpyruvate tautomerase activity catalysed by macrophage migration inhibitory factor (MIF)

D. Oliver, P. P. Haasbroek, J. M. A. Carpy, 2010 .

Design and synthesis of 2,4-difluorophenylpyruvic acid and of its azlactone precursor for macrophage migration inhibitory factor (MIF) tautomerase activity

D. Oliver, A. Carpy, P. P. Haasbroek, 2004 .

Evidence of the structure of 4-(4′-acetoxybenzylidene)-2-methyl-5-oxazolone and its phenylpropenoic acid derivatives

D. Oliver, A. Carpy, P. P. Haasbroek, 2003 .

Crystallographic and NMR evidence for the enol tautomer of 3-methoxy-4-hydroxy-5-chloro-phenylpyruvic acid

J. Leger, D. Oliver, A. Carpy, 1994 .

3‐Phenyl‐D3‐Trishomocuban‐4‐ol: Structure and Configuration

D. Oliver, A. Carpy, 1994 .

Keto/enol tautomerism in phenylpyruvic acids: structure of the o-nitrophenylpyruvic acid

D. Oliver, A. Carpy, J. Ouhabi, 2000 .

Structure of 4-(2-chloro-4,5-dimethoxybenzylidene)-2-methyl-5-oxazolone. X-ray and NMR study

D. Oliver, A. Carpy, P. P. Haasbroek, 1998 .

Structure of 2-acetoxy-3-(3-methoxy-4-acetoxy-5-chlorophenyl)-propenoic acid

D. Oliver, A. Carpy, P. P. Haasbroek, 1998 .

Evidence for multiple binding modes to the μ-opioid receptor

G. Marshall, D. Oliver, 1991 .

Enol tautomer of the acetate ester of 3-methoxy-4-hydroxyphenylpyruvic acid: Crystallographic and NMR spectroscopic evidence

D. Oliver, A. Carpy, P. P. Haasbroek, 1998 .

Drug Effects on Cerebral Blood Flow in the Baboon Model - Acetazolamide and Nimodipine

D. Oliver, I. Dormehl, N. Hugo, 1993, Nuklearmedizin.

Effect of Cyclodextrin Complexation on the in vivo Disposition of the Brain Imaging Radiopharmaceutical 99mTechnetium Ethyl Cysteinate Dimer (99mTc-ECD)

D. Oliver, W. Louw, E. Kilian, 2000, Arzneimittelforschung.

A comparative cerebral blood flow study in a baboon model with acetazolamide provocation: 99mTc-HMPAO vs 123I(IMP).

D. Oliver, I. Dormehl, N. Hugo, 1995, Nuclear medicine and biology.

The baboon model under anesthesia for in vivo cerebral blood flow studies using single photon emission computed tomographic (SPECT) techniques.

D. Oliver, I. Dormehl, N. Hugo, 1992, Journal of medical primatology.

Dose response from pharmacological interventions for CBF changes in a baboon model using 99Tcm-HMPAO and SPECT.

D. Oliver, I. Dormehl, N. Hugo, 1993, Nuclear medicine communications.

Cerebral blood flow effects of sumatriptan in drug combinations in the baboon model.

D. Oliver, I. Dormehl, N. Hugo, 1995, Arzneimittel-Forschung.

Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study.

H. Müller-Gärtner, S. Pond, N. Castagnoli, 1996, Brain research. Molecular brain research.

Studies on cellular resilience and adaptation following acute and repetitive exposure to ozone in cultured human epithelial (HeLa) cells

D. Oliver, C. B. Brink, Anita Pretorius, 2008, Redox report : communications in free radical research.